Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ALKS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
71 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 12 days ago
Red flags: 0
423 filers reported a long position in ALKS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $1.5B | 29.2M | +3.3% |
| BAKER BROS. ADVISORS LP | $524.6M | 10M | Unchanged |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $497.3M | 9.5M | -0.2% |
| STATE STREET CORP | $480M | 9.2M | -3.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $393.7M | 7.5M | +1.2% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $353M | 6.7M | +44.4% |
| RENAISSANCE TECHNOLOGIES LLC | $338.5M | 6.5M | +4.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $234.7M | 4.5M | +7.1% |
| DIMENSIONAL FUND ADVISORS LP | $219.8M | 4.2M | -7.2% |
| Deep Track Capital, LP | $209.6M | 4M | +11.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.